These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 19360307)
1. The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes. Schmidt M; Polednik C; Gruensfelder P; Roller J; Hagen R Oncol Rep; 2009 May; 21(5):1297-305. PubMed ID: 19360307 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells. Schmidt M; Polednik C; Roller J; Hagen R Oncol Rep; 2013 Feb; 29(2):628-36. PubMed ID: 23165347 [TBL] [Abstract][Full Text] [Related]
3. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition. Bonham MJ; Galkin A; Montgomery B; Stahl WL; Agus D; Nelson PS J Natl Cancer Inst; 2002 Nov; 94(21):1641-7. PubMed ID: 12419791 [TBL] [Abstract][Full Text] [Related]
4. PC-SPES inhibits colon cancer growth in vitro and in vivo. Huerta S; Arteaga JR; Irwin RW; Ikezoe T; Heber D; Koeffler HP Cancer Res; 2002 Sep; 62(18):5204-9. PubMed ID: 12234985 [TBL] [Abstract][Full Text] [Related]
5. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo . Kubota T; Hisatake J; Hisatake Y; Said JW; Chen SS; Holden S; Taguchi H; Koeffler HP Prostate; 2000 Feb; 42(3):163-71. PubMed ID: 10639186 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment. Schwarz RE; Donohue CA; Sadava D; Kane SE Cancer Lett; 2003 Jan; 189(1):59-68. PubMed ID: 12445678 [TBL] [Abstract][Full Text] [Related]
7. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells. Ikezoe T; Chen S; Saito T; Asou H; Kyo T; Tanosaki S; Heber D; Taguchi H; Koeffler HP Int J Oncol; 2003 Oct; 23(4):1203-11. PubMed ID: 12964005 [TBL] [Abstract][Full Text] [Related]
8. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells. Sadava D; Winesburg J Cancer Lett; 2005 Apr; 220(2):171-5. PubMed ID: 15766592 [TBL] [Abstract][Full Text] [Related]
9. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Sadava D; Ahn J; Zhan M; Pang ML; Ding J; Kane SE Cancer Chemother Pharmacol; 2002 Apr; 49(4):261-6. PubMed ID: 11914903 [TBL] [Abstract][Full Text] [Related]
10. In vitro mechanism of PC SPES. Chenn S Urology; 2001 Aug; 58(2 Suppl 1):28-35; discussion 38. PubMed ID: 11502443 [TBL] [Abstract][Full Text] [Related]
11. Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines. Sakakibara A; Tsukuda M; Kondo N; Ishiguro Y; Kimura M; Fujita K; Takahashi H; Matsuda H Auris Nasus Larynx; 2011 Oct; 38(5):589-99. PubMed ID: 21362583 [TBL] [Abstract][Full Text] [Related]
12. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA]. Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562 [TBL] [Abstract][Full Text] [Related]
13. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991 [TBL] [Abstract][Full Text] [Related]
14. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients. de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984 [TBL] [Abstract][Full Text] [Related]
15. Prevention and management of prostate cancer using PC-SPES: a scientific perspective. Hsieh TC; Lu X; Chea J; Wu JM J Nutr; 2002 Nov; 132(11 Suppl):3513S-3517S. PubMed ID: 12421879 [TBL] [Abstract][Full Text] [Related]
16. BMSC enhance the survival of paclitaxel treated squamous cell carcinoma cells in vitro. Scherzed A; Hackenberg S; Froelich K; Kessler M; Koehler C; Hagen R; Radeloff A; Friehs G; Kleinsasser N Cancer Biol Ther; 2011 Feb; 11(3):349-57. PubMed ID: 21127403 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. DiPaola RS; Zhang H; Lambert GH; Meeker R; Licitra E; Rafi MM; Zhu BT; Spaulding H; Goodin S; Toledano MB; Hait WN; Gallo MA N Engl J Med; 1998 Sep; 339(12):785-91. PubMed ID: 9738085 [TBL] [Abstract][Full Text] [Related]
18. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. de la Taille A; Buttyan R; Hayek O; Bagiella E; Shabsigh A; Burchardt M; Burchardt T; Chopin DK; Katz AE J Urol; 2000 Oct; 164(4):1229-34. PubMed ID: 10992371 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells. Hsieh TC; Wu JM Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572 [TBL] [Abstract][Full Text] [Related]
20. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Bonham M; Arnold H; Montgomery B; Nelson PS Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]